Arena Pharmaceuticals (ARNA) Tops Q2 Loss Views by 1c

August 3, 2010 4:05 PM EDT
Arena Pharmaceuticals (Nasdaq: ARNA) reports Q2 loss of $0.28, cents better than the analyst estimate of ($0.29). Revenue for the quarter was $2.46 million, which compares to the estimate of $2.97 million.

You May Also Be Interested In

Related Categories


Add Your Comment